PS49. Shifted Circadian Phase in Manic Episode was Returned to Normal after Treatment in Bipolar Disorder [PDF]
Cho, Chul-Hyun +13 more
core
A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]
Harikul W +6 more
europepmc +1 more source
Second-Generation Antipsychotics for Depression in Serious Illness: A First-Line Augmentation Strategy. [PDF]
Robbins-Welty G +7 more
europepmc +1 more source
Safety, Tolerability, and Pharmacokinetics of Subcutaneous Extended-Release Injectable Olanzapine in Patients with Schizophrenia and Schizoaffective Disorder. [PDF]
Cherniakov I +13 more
europepmc +1 more source
Olanzapine Overdose-Induced Bradycardia in a Young Adult With Major Depressive Disorder: A Case Report and Literature Review. [PDF]
Palangi MG +3 more
europepmc +1 more source
Thromboembolic events with olanzapine: a systematic review integrating meta-analysis and FAERS database. [PDF]
Zhang X +8 more
europepmc +1 more source
Commentary: Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system. [PDF]
Price MZ, Price RL.
europepmc +1 more source
The Impact of Sex and Age on Antipsychotic Serum Concentrations. [PDF]
de Beer F +7 more
europepmc +1 more source
Beyond antipsychotic efficacy and toward an individualized therapeutic strategy: analysis of the systemic, metabolic, and inflammatory effects of olanzapine, haloperidol, and their combination in schizophrenic patients. [PDF]
Alharbi NS +6 more
europepmc +1 more source
Efficacy of short-term, low-dose oral olanzapine at reducing perioperative anxiety, pain, and enhancing recovery in patients undergoing primary total joint arthroplasty. [PDF]
Jiang B +6 more
europepmc +1 more source

